CLINICAL_TRIALS
research
· 2017-04-25
Clinical Trial Update: Study of The Therapeutic Benefits of Al-hijamah in Children With Beta Thalassemia Major [NA]
Summary
A clinical trial update evaluating Al-hijamah as a treatment for beta-thalassemia major in children; the current status is unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Tanta University | Conditions: AL-Hijama in Thalassmia Major | NA | Status: UNKNOWN